Citation: S. Koba et al., VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION INDUCED BY THE INTERACTION BETWEEN SEROTONIN (5HT) AND MILDLY OXIDIZED LOW-DENSITY-LIPOPROTEIN, IS REVERSED BY 5HT(2) RECEPTOR ANTAGONIST OR PERTUSSIS TOXIN, Journal of the American College of Cardiology, 31(2), 1998, pp. 24-24
Citation: S. Koba et al., BETA-LIPOPROTEINS FROM HYPERCHOLESTEROLEMIC RABBITS MARKEDLY POTENTIATE THE MITOGENIC EFFECT OF SEROTONIN ON VASCULAR SMOOTH-MUSCLE CELLS, Journal of the American College of Cardiology, 31(2), 1998, pp. 61-61
Authors:
BENEDICT CR
CHEN ZQ
PAWASHE AB
EZEKOWITZ MD
Citation: Cr. Benedict et al., INHIBITION OF ARTERIAL THROMBOSIS - SYNERGISTIC INTERACTION BETWEEN PLATELET IIB IIIA RECEPTOR AND TISSUE FACTOR/, Journal of the American College of Cardiology, 31(2), 1998, pp. 498-499
Authors:
ALCHANATI I
PATEL JAA
LIU JG
BENEDICT CR
STIPANOVIC RD
BELL AA
CUI YX
MAGILL CW
Citation: I. Alchanati et al., THE ENZYMATIC CYCLIZATION OF NEROLIDYL DIPHOSPHATE BY DELTA-CADINENE SYNTHASE FROM COTTON STELE TISSUE INFECTED WITH VERTICILLIUM-DAHLIAE, Phytochemistry, 47(6), 1998, pp. 961-967
Citation: R. Pakala et Cr. Benedict, EFFECT OF SEROTONIN AND THROMBOXANE A(2) ON ENDOTHELIAL-CELL PROLIFERATION - EFFECT OF SPECIFIC RECEPTOR ANTAGONISTS, The Journal of laboratory and clinical medicine, 131(6), 1998, pp. 527-537
Authors:
GROTE TH
PINEDA LF
FIGLIN RA
PENDERGRASS KB
HESKETH PJ
KARLAN BY
REEVES JA
PORTER LL
BENEDICT CR
HAHNE WF
Citation: Th. Grote et al., ORAL DOLASETRON MESYLATE IN PATIENTS RECEIVING MODERATELY EMETOGENIC PLATINUM-CONTAINING CHEMOTHERAPY, The cancer journal from Scientific American, 3(1), 1997, pp. 45-51
Citation: R. Pakala et al., EICOSAPENTAENOIC ACID (EPA) AND DOCOSAHEXAENOIC ACID (DHA) PREINCUBATED VASCULAR SMOOTH-MUSCLE CELLS (SMC) FAIL TO RESPOND TO THROMBOXANE A(2) INDUCED MITOGENICITY, The FASEB journal, 11(3), 1997, pp. 894-894
Citation: R. Pakala et Cr. Benedict, SPERMINE, A NOVEL ANTITHROMBOTIC AGENT - PREVENTION OF ARTERIAL THROMBOSIS IN A CANINE MODEL, Journal of the American College of Cardiology, 29(2), 1997, pp. 6160-6160
Authors:
FOWLER MB
VAGELOS RH
SCHROEDER JS
BENEDICT CR
WILLSON K
BOUCHER M
MULLIN A
PRIKAZSKY LM
LISS CL
LABELLE P
Citation: Mb. Fowler et al., COMPARISON OF HIGH VERSUS LOW-DOSE ENALAPRIL THERAPY ON CLINICAL OUTCOMES AND NEUROENDOCRINE ACTIVATION IN ADVANCED HEART-FAILURE, Circulation, 96(8), 1997, pp. 105-105
Authors:
BENEDICT CR
TODD J
ZHU BY
SCARBOROUGH RM
SINHA U
Citation: Cr. Benedict et al., FACTOR XA ANTAGONIST (C921-78) INHIBITS ARTERIAL THROMBOSIS WITHOUT IMPAIRMENT OF EXTRAVASCULAR HEMOSTATIS, Circulation, 96(8), 1997, pp. 220-220
Authors:
SABBAH HN
TANIMURA M
MISHIMA T
BENEDICT CR
HEGDE SS
GOLDSTEIN S
Citation: Hn. Sabbah et al., EFFECTS OF LONG-TERM THERAPY WITH NEPICASTAT (RS-25560-197), A DOPAMINE-BETA-HYDROXYLASE INHIBITOR, ON LEFT-VENTRICULAR FUNCTION AND REMODELING IN DOGS WITH MODERATE HEART-FAILURE, Circulation, 96(8), 1997, pp. 508-508
Authors:
BENEDICT CR
GOTTLIEB SS
MASSIE BM
GHALI JK
MCKINNON SA
FRIDAY KJ
Citation: Cr. Benedict et al., MODULATION OF SYMPATHETIC ACTIVATION IN PATIENTS WITH HEART-FAILURE BY NEPICASTAT (RS-25560-197) - A DOPAMINE-BETA-HYDROXYLASE INHIBITOR, Circulation, 96(8), 1997, pp. 509-509
Citation: R. Pakala et al., EFFECT OF SEROTONIN, THROMBOXANE A(2), AND SPECIFIC RECEPTOR ANTAGONISTS ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION, Circulation, 96(7), 1997, pp. 2280-2286
Citation: P. Thiagarajan et Cr. Benedict, INHIBITION OF ARTERIAL THROMBOSIS BY RECOMBINANT ANNEXIN-V IN A RABBIT CAROTID-ARTERY INJURY MODEL, Circulation, 96(7), 1997, pp. 2339-2347
Authors:
WEINBERG EO
LEE MA
WEIGNER M
LINDPAINTNER K
BISHOP SP
BENEDICT CR
HO KKL
DOUGLAS PS
CHAFIZADEH E
LORELL BH
Citation: Eo. Weinberg et al., ANGIOTENSIN AT(1) RECEPTOR INHIBITION - EFFECTS ON HYPERTROPHIC REMODELING AND ACE EXPRESSION IN RATS WITH PRESSURE-OVERLOAD HYPERTROPHY DUE TO ASCENDING AORTIC-STENOSIS, Circulation, 95(6), 1997, pp. 1592-1600
Authors:
RUBENSTEIN EB
GRALLA RJ
HAINSWORTH JD
HESKETH PJ
GROTE TH
MODIANO MR
KHOJASTEH A
KALMAN LA
BENEDICT CR
HAHNE WF
Citation: Eb. Rubenstein et al., RANDOMIZED, DOUBLE-BLIND, DOSE-RESPONSE TRIAL ACROSS 4 ORAL DOSES OF DOLASETRON FOR THE PREVENTION OF ACUTE EMESIS AFTER MODERATELY EMETOGENIC CHEMOTHERAPY, Cancer, 79(6), 1997, pp. 1216-1224
Citation: P. Thiagarajan et al., BETA-2-GLYCOPROTEIN-I MODULATES CALCIUM-INDUCED FUSION OF PHOSPHATIDYLSERINE VESICLES, Blood, 90(10), 1997, pp. 3168-3168
Authors:
PATTEN RD
KRONENBERG MW
BENEDICT CR
UDELSON JE
KINAN D
STEWART D
YUSUF S
SMITH JJ
KILCOYNE L
DOLAN N
EDENS TR
METHERALL J
KONSTAM MA
Citation: Rd. Patten et al., ACUTE AND LONG-TERM EFFECTS OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, ENALAPRIL, ON ADRENERGIC ACTIVITY AND SENSITIVITY DURING EXERCISE IN PATIENTS WITH LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION, The American heart journal, 134(1), 1997, pp. 37-43
Authors:
ROUSSEAU MF
HAYASHIDA W
VANEYLL C
HESS OM
BENEDICT CR
AHN S
CHAPELLE F
KOBRIN I
POULEUR H
Citation: Mf. Rousseau et al., HEMODYNAMIC AND CARDIAC EFFECTS OF THE SELECTIVE T-TYPE AND L-TYPE CALCIUM-CHANNEL BLOCKING-AGENT MIBEFRADIL IN PATIENTS WITH VARYING DEGREES OF LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION, Journal of the American College of Cardiology, 28(4), 1996, pp. 972-979
Citation: Jg. Liu et al., SYNTHESIS OF A TRITIUM-LABELED PHOTOLABILE ANALOG OF FARNESYL DIPHOSPHATE - )-[1-H-3]-(2-DIAZO-3-TRIFLUOROPROPIONYLOXY)GERANYL DIPHOSPHATE (DATFP-GDP), Journal of labelled compounds & radiopharmaceuticals, 38(2), 1996, pp. 139-148